Careers
News and Events
Investors
Find solutions
Business Challenges
Strategic partnering
Biosimilar development and marketing
Early sell or out-license?
Acquire or partner, develop, market
Discover, develop, market
Acquire to distribute
Manage product lifecycle
Acquire, develop, and sell
Risk management
Pharmacovigilance
Emerging Regions
Flexible Outsourcing Models
Clinical Stages
Early stage studies: Phase I/IIa
Pivotal clinical trials: Phase IIb/III
Peri-approval/post-marketing studies: Phase IIIb/IV
Therapy
Cardiovascular and metabolic diseases
Central nervous system (CNS) disorders
Infectious disease
Oncology and hematology
Other therapeutic areas
The PAREXEL difference
About
Management team
Find an office
Experience and expertise
eClinical innovation
Businesses we serve
Why PAREXEL?
Services and Capabilities
PAREXEL Consulting
Early Phase
Clinical Research
Peri/Post Approval
Medical Communications
PAREXEL Akademie
Technology
ClinPhone RTSM
Imaging
CTMS
EDC
ePRO
Solutions
About
Management team
Find an office
Experience and expertise
eClinical innovation
Businesses we serve
Why PAREXEL?
Advanced contact
News and events
Services and capabilities
PAREXEL Consulting
Early Phase
Clinical Research
Late Phase
Medical Communications
PAREXEL Akademie
Clinical stages
Early stage studies: Phase I/IIa
Pivotal clinical trials: Phase IIb/III
Peri-approval/post-marketing studies: Phase IIIb/IV
Therapies
Cardiovascular and metabolic diseases
Central nervous system (CNS) disorders
Infectious disease
Oncology and hematology
Other therapeutic areas
Technology
ClinPhone RTSM
Imaging
CTMS
EDC
ePRO
Solutions
Business Challenges
Strategic partnering
Biosimilar development and marketing
Early sell or out-license?
Acquire or partner, develop, market
Discover, develop, market
Acquire to distribute
Manage product lifecycle
Acquire, develop, and sell
Risk management
Pharmacovigilance
Emerging Regions
